Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Traws Pharma (TRAW) Intangibles (2025)

Traws Pharma (TRAW) has disclosed Intangibles for 1 consecutive years, with $2.6 million as the latest value for Q4 2025.

  • For Q4 2025, Intangibles changed N/A year-over-year to $2.6 million; the TTM value through Dec 2025 reached $2.6 million, changed N/A, while the annual FY2025 figure was $2.6 million, N/A changed from the prior year.
  • Intangibles hit $2.6 million in Q4 2025 for Traws Pharma, roughly flat from $2.6 million in the prior quarter.
  • Across five years, Intangibles topped out at $2.6 million in Q3 2025 and bottomed at $2.6 million in Q3 2025.